Form 4: Amgen EVP & CFO Peter H. Griffith Reports Changes in Beneficial Ownership

Peter H. Griffith, EVP & CFO of Amgen Inc., reports a transaction involving common stock on March 17, 2025, resulting in an adjusted beneficial ownership.

Summary

• On March 17, 2025, Peter H. Griffith, the EVP & CFO of Amgen Inc., filed a Form 4 to report changes in beneficial ownership of Amgen's common stock.
• The transaction involved the disposal of 3,305 shares at a price of $313.71.
• Following the reported transaction, Griffith directly owns 40,334 shares of Amgen common stock, which includes 762 Dividend Equivalents (DEs).

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine disclosure of stock transactions by an executive.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to the market.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it reflects an insider's perspective on the company's stock value.

Key Dates

Keywords

Form 4, Beneficial Ownership, Amgen, AMGN, Peter H. Griffith, EVP & CFO, Dividend Equivalents, Equity Incentive Plan, Common Stock